ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2015

Abstract Number: 2597

Fine Specificity of Anti-Citrullinated Peptide Antibodies Is Associated with Left Ventricular Mass Index in Rheumatoid Arthritis Patients without Cardiovascular Disease

Laura Geraldino-Pardilla1, Jon T. Giles2, Jeremy Sokolove3, Afshin Zartoshti4, WH Robinson5 and Joan M. Bathon6, 1Division of Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 2Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 3Medicine, VA Palo Alto HealthCare System and Stanford University, Palo Alto, CA, 4Rheumatology, Columbia University Medical Center, NY, NY, 5Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 6Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2015

Date of first publication: September 29, 2015

Keywords: ACPA, heart disease and rheumatoid arthritis (RA)

Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Heart failure (HF) is a leading
cause of excess deaths in RA. We previously found an association between left
ventricular mass index (LVMI) and anti-citrullinated peptide antibodies (ACPA)
in rheumatoid arthritis (RA) patients without CVD. Our objective was to validate
these findings in a different RA cohort of patients without CVD.

Methods:  Seventy-four patients without
known CVD from underwent 3D Echocardiography and concurrent serum testing of a
panel of 30 specific ACPAs using a custom Bio-Plex bead array. With a high ACPA
level defined as ≥ 75th percentile, a cross-sectional analysis
of the association of specific ACPAs and LVMI was performed. Traditional CVD
risk factors and RA characteristics were adjusted for.

Results: The mean age of the patients was 54
years (±13), with 85% being females and 36% self-identified as non-Hispanic White.
The median disease duration was 7 years (IQR: 3-17), 67% had a positive
anti-CCP antibody, and the mean current RA disease activity, based on the DAS28-CRP,
was 3.9 (IQR: 2.9-4.5). Forty percent were hypertensive, 11% had diabetes, and
7% were current smokers. Except for a higher proportion of patients with
rheumatoid factor level> 40units, no differences were seen between those
with high vs. low anti-CCP titers. High anti-citrullinated fibrinogen, anti-citrullinated
vimentin, and anti-citrullinated fibronectin antibody levels were associated
with a higher LVMI compared to low levels of these antibodies (68 vs. 58 g/m2,
p=0.02; 67 vs. 58 g/m2, p=0.003; and 69 vs. 57 g/m2,
p=0.004; respectively).  These associations remained significant in the
adjusted analyses (69 vs. 58 g/m2, p=0.04; 67 vs. 58 g/m2,
p=0.004; 72 vs. 57 g/m2, p=0.009; respectively) (figure 1).

Conclusion: In concordance with our previous findings, specific ACPAs were associated with a
higher LVMI in RA patients without CVD. This independent association suggests a
link between autoimmunity and cardiac structure in RA.

Figure 1. Association of ACPA status with Left Ventricular mass
index.

Figure 1. High anti-citrullinated-vimentin, anti-citrullinated-fibrinogen,
and anti-citrullinated fibronectin antibody levels were associated with higher
LVMI. *Adjusted for hypertension.

 


Disclosure: L. Geraldino-Pardilla, None; J. T. Giles, None; J. Sokolove, None; A. Zartoshti, None; W. Robinson, None; J. M. Bathon, None.

To cite this abstract in AMA style:

Geraldino-Pardilla L, Giles JT, Sokolove J, Zartoshti A, Robinson W, Bathon JM. Fine Specificity of Anti-Citrullinated Peptide Antibodies Is Associated with Left Ventricular Mass Index in Rheumatoid Arthritis Patients without Cardiovascular Disease [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/fine-specificity-of-anti-citrullinated-peptide-antibodies-is-associated-with-left-ventricular-mass-index-in-rheumatoid-arthritis-patients-without-cardiovascular-disease/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fine-specificity-of-anti-citrullinated-peptide-antibodies-is-associated-with-left-ventricular-mass-index-in-rheumatoid-arthritis-patients-without-cardiovascular-disease/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology